MyJournals Home  

RSS FeedsPharmaceuticals, Vol. 15, Pages 134: Tunicamycin Protects against LPS-Induced Lung Injury (Pharmaceuticals)


24 january 2022 08:27:43

Pharmaceuticals, Vol. 15, Pages 134: Tunicamycin Protects against LPS-Induced Lung Injury (Pharmaceuticals)

The pulmonary endothelium is a dynamic semipermeable barrier that orchestrates tissue-fluid homeostasis; regulating physiological and immunological responses. Endothelial abnormalities are caused by inflammatory stimuli interacting with intracellular messengers to remodel cytoskeletal junctions and adhesion proteins. Those phenomena are associated with sepsis, acute lung injury, and acute respiratory distress syndrome. The molecular processes beyond those responses are the main interest of our group. Unfolded protein response (UPR) is a highly conserved molecular pathway resolving protein-folding defects to counteract cellular threats. An emerging body of evidence suggests that UPR is a promising target against lung and cardiovascular disease. In the present study, we reveal that Tunicamycin (TM) (UPR inducer) protects against lipopolysaccharide (LPS)-induced injury. The barrier function of the inflamed endothelium was evaluated in vitro (transendothelial and paracellular permeability); as well as in mice exposed to TM after LPS. Our study demonstrates that TM supports vascular barrier function by modulating actomyosin remodeling. Moreover, it reduces the internalization of vascular endothelial cadherin (VE-cadherin), enhancing endothelial integrity. We suggest that UPR activation may deliver novel therapeutic opportunities in diseases related to endothelial dysregulation.

78 viewsCategory: Medicine, Pharmacology
Pharmaceuticals, Vol. 15, Pages 133: Methylomic Biomarkers of Lithium Response in Bipolar Disorder: A Proof of Transferability Study (Pharmaceuticals)
Pharmaceuticals, Vol. 15, Pages 135: Laboratory Selection of Trypanosomatid Pathogens for Drug Resistance (Pharmaceuticals)
blog comments powered by Disqus
The latest issues of all your favorite science journals on one page


Register | Retrieve



Copyright © 2008 - 2022 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten